skip to primary navigationskip to content
 

Responsive Polymer Chemistry

Mark Cambridge UK, April 9, 2003, Vivamer Ltd announces that it has secured seed finance from the University of Cambridge Challenge Fund. Professor Nigel Slater and Dr Mark Eccleston (pictured left) of the Department of Chemical Engineering, University of Cambridge, founded Vivamer to commercialise their responsive polymer chemistry. The seed financing will be used to demonstrate the utility of Vivamer's technology in the areas of diagnostic imaging and drug delivery for anti-cancer applications.

Responsive polymers react to their environment and can be designed to act as a molecular switch turning on or off chemical properties associated with payload compounds. For example, in response to a change in pH at a site of disease, a Vivamer polymer could release a drug payload, delivering the drug directly to the site of disease. The technology has numerous applications including healthcare, household chemicals and food technology.

"Responsive polymers offer a number of compelling benefits in healthcare applications," said Professor Slater. "By releasing drugs or activating imaging agents in response to the disease environment you have greater control over the patient’s treatment".

Bill Mathews commented, "Vivamer is the latest company to emerge from Cambridge University, and demonstrates the university’s continuing expertise in commercializing world class inventions. We believe that Vivamer's chemistry platform has the potential to deliver significant value to its commercial partners across a range of industries".

Vivamer was founded in December 2002 to commercialise responsive polymer chemistry developed by Professor Nigel Slater and Mark Eccleston. Professor Slater's work at Cambridge focuses on Bio-products manufacturing and functional, bio-mimetic materials and his work is related to the Bioscience engineering research theme.

The University of Cambridge Challenge Fund provides seed finance to companies spun out of the University of Cambridge. It has made investments in 11 companies including Daniolabs, Akubio and Cambridge Semiconductor since it was set up in 2000.

RSS Feed Latest news

SPARC success for CEB-India research collaboration

Feb 18, 2019

Scheme for Promotion of Academic and Research Collaboration (SPARC) grant awarded to CEB- Indian Institute of Technology Roorkee research collaboration.

Ineos Oxide Summer Intern Scheme launched at CEB

Feb 08, 2019

Ineos Oxide is looking for talented undergrad chemical engineering students to join their summer intern scheme and help them solve real-world problems.

New EPSRC Sensors CDT

Feb 05, 2019

New EPSRC Centre for Doctoral Training in Sensor Technologies and Applications for a Healthy and Sustainable Future at CEB.

View all news

Upcoming events

Celebrating LGBT and History Month

Feb 01, 2019

University-wide

Science Festival at CEB

Mar 23, 2019

CEB, Phillippa Fawcett Drive

Stokes200 Symposium

Sep 15, 2019

Pembroke College, Cambridge

VPF8 Viscoplastic Fluids: from Theory to Application 2019

Sep 16, 2019

Jesus College, Cambridge

Upcoming events